Episode #17 The Low FODMAPs Diet with Dr. Peter Gibson

Body of Wonder Podcast

Irritable Bowel Syndrome (IBS) is one of the most common gastrointestinal disorders, affecting more than 10% of the population. Symptoms include chronic constipation, diarrhea, or acute abdominal pain a short time after eating. The unpredictable and disruptive nature of these symptoms along with their emotional toll can lead to heightened levels of stress, which in turn, may worsen symptoms.

Our guest on this episode is Dr. Peter Gibson, Professor and Director of Gastroenterology at The Alfred and Monash University in Australia. Prof. Gibson’s clinical research has revealed a surprising link between certain carbohydrates and gut dysfunction. On the episode, he explains how FODMAPs (which stands for fermentable oligosaccharides, disaccharides, monosaccharides and polyols) slowly digest in the gut releasing gas and drawing in excess water thereby interfering with normal GI function. Together with his research team at Monash University, Dr. Gibson has developed the Low-FODMAP Diet which temporarily eliminates certain foods thus preventing fermentation and providing relief to sensitive colons.

Drs. Weil, Maizes, and Gibson discuss the ins and outs and complexities of following a low FODMAP diet and the value of this useful tool for relieving the symptoms of IBS as well as other GI disorders.

Please note, the show will not advise, diagnose, or treat medical conditions. Always seek the advice of your physician or healthcare provider for questions regarding your health.

Play Episode


Andrew Weil, MD and Victoria Maizes, MD


Peter Gibson

Peter Gibson is Professor and Director of Gastroenterology at The Alfred and Monash University, having previously been Professor of Medicine at Eastern Health and Head of the Eastern Health Clinical School. He is a Past-President of the Gastroenterological Society of Australia. From a background of research in epithelial cell biology, he now directs a large program of translational research, and has active clinical interests in inflammatory bowel disease, coeliac disease and irritable bowel syndrome. Major foci of his work include the use of diet to control gut symptoms and influence outcomes in chronic intestinal conditions, and the optimization of clinical management in inflammatory bowel disease. He has published widely on these topics. He was awarded the Distinguished Research Prize by the Gastroenterological Society of Australia in 2010.
See more